Desjardins Group
Desjardins Group, established in 1900, is a cooperative financial group based in Montreal, Canada. It offers a wide range of financial services to individuals and businesses, including personal banking, credit and loans, investments, insurance, and wealth management. Through its subsidiary, Desjardins Capital, the group provides venture capital and development capital to businesses and cooperatives across various sectors such as healthcare, manufacturing, technology, and agriculture. Desjardins Capital invests in startups, early-stage, and mature companies, typically providing equity or debt financing ranging from $0.09 million to $20 million for periods of 3 to 10 years. The group also offers corporate financing, debt capital markets, and equity capital markets services through its Desjardins Securities division.
NeuroServo
Seed Round in 2023
NeuroServo has developed VEEGix, an innovative miniaturized prefrontal electroencephalogram (EEG) device tailored for emergency use in Intensive Care Units. Unlike traditional EEGs, which require extensive setup by technicians and neurologists, often leading to delays of up to four hours, VEEGix can be quickly installed by nursing staff to deliver immediate brain status assessments within a minute. This device is designed to function as an emergency EEG, crucial for timely intervention in critical cases where treatment windows are extremely short, thereby reducing the risk of permanent brain damage. Additionally, VEEGix serves as a cerebral monitoring tool for patients under sedation, enhancing patient care in high-stakes medical environments.
NeuroServo
Seed Round in 2018
NeuroServo has developed VEEGix, an innovative miniaturized prefrontal electroencephalogram (EEG) device tailored for emergency use in Intensive Care Units. Unlike traditional EEGs, which require extensive setup by technicians and neurologists, often leading to delays of up to four hours, VEEGix can be quickly installed by nursing staff to deliver immediate brain status assessments within a minute. This device is designed to function as an emergency EEG, crucial for timely intervention in critical cases where treatment windows are extremely short, thereby reducing the risk of permanent brain damage. Additionally, VEEGix serves as a cerebral monitoring tool for patients under sedation, enhancing patient care in high-stakes medical environments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.